COVISTA INC (CVSA) Fundamental Analysis & Valuation

NYSE:CVSA • US00737L1035

Current stock price

106.49 USD
-0.49 (-0.46%)
At close:
106.49 USD
0 (0%)
After Hours:

This CVSA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

8

1. CVSA Profitability Analysis

1.1 Basic Checks

  • In the past year CVSA was profitable.
  • In the past year CVSA had a positive cash flow from operations.
  • CVSA had positive earnings in each of the past 5 years.
  • Each year in the past 5 years CVSA had a positive operating cash flow.
CVSA Yearly Net Income VS EBIT VS OCF VS FCFCVSA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M 300M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 9.69%, CVSA belongs to the top of the industry, outperforming 82.19% of the companies in the same industry.
  • CVSA has a Return On Equity of 18.37%. This is amongst the best in the industry. CVSA outperforms 83.56% of its industry peers.
  • CVSA has a Return On Invested Capital of 13.77%. This is amongst the best in the industry. CVSA outperforms 89.04% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for CVSA is in line with the industry average of 10.88%.
  • The last Return On Invested Capital (13.77%) for CVSA is above the 3 year average (9.63%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 9.69%
ROE 18.37%
ROIC 13.77%
ROA(3y)5.64%
ROA(5y)5.9%
ROE(3y)10.98%
ROE(5y)11.83%
ROIC(3y)9.63%
ROIC(5y)7.66%
CVSA Yearly ROA, ROE, ROICCVSA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 -5 10 15 20

1.3 Margins

  • Looking at the Profit Margin, with a value of 13.41%, CVSA belongs to the top of the industry, outperforming 84.93% of the companies in the same industry.
  • CVSA's Profit Margin has declined in the last couple of years.
  • CVSA has a Operating Margin of 19.55%. This is amongst the best in the industry. CVSA outperforms 83.56% of its industry peers.
  • In the last couple of years the Operating Margin of CVSA has grown nicely.
  • CVSA's Gross Margin of 57.38% is fine compared to the rest of the industry. CVSA outperforms 73.97% of its industry peers.
  • CVSA's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 19.55%
PM (TTM) 13.41%
GM 57.38%
OM growth 3Y19.65%
OM growth 5Y4.08%
PM growth 3Y-16.17%
PM growth 5YN/A
GM growth 3Y2.86%
GM growth 5Y1.26%
CVSA Yearly Profit, Operating, Gross MarginsCVSA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. CVSA Health Analysis

2.1 Basic Checks

  • CVSA has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • The number of shares outstanding for CVSA has been reduced compared to 1 year ago.
  • CVSA has less shares outstanding than it did 5 years ago.
  • The debt/assets ratio for CVSA has been reduced compared to a year ago.
CVSA Yearly Shares OutstandingCVSA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
CVSA Yearly Total Debt VS Total AssetsCVSA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

2.2 Solvency

  • CVSA has an Altman-Z score of 4.47. This indicates that CVSA is financially healthy and has little risk of bankruptcy at the moment.
  • CVSA has a Altman-Z score of 4.47. This is amongst the best in the industry. CVSA outperforms 86.30% of its industry peers.
  • The Debt to FCF ratio of CVSA is 1.37, which is an excellent value as it means it would take CVSA, only 1.37 years of fcf income to pay off all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 1.37, CVSA belongs to the top of the industry, outperforming 83.56% of the companies in the same industry.
  • CVSA has a Debt/Equity ratio of 0.37. This is a healthy value indicating a solid balance between debt and equity.
  • Looking at the Debt to Equity ratio, with a value of 0.37, CVSA is in line with its industry, outperforming 50.68% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.37
Debt/FCF 1.37
Altman-Z 4.47
ROIC/WACC1.58
WACC8.73%
CVSA Yearly LT Debt VS Equity VS FCFCVSA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B 1.5B

2.3 Liquidity

  • CVSA has a Current Ratio of 0.68. This is a bad value and indicates that CVSA is not financially healthy enough and could expect problems in meeting its short term obligations.
  • CVSA has a Current ratio of 0.68. This is in the lower half of the industry: CVSA underperforms 75.34% of its industry peers.
  • A Quick Ratio of 0.68 indicates that CVSA may have some problems paying its short term obligations.
  • With a Quick ratio value of 0.68, CVSA is not doing good in the industry: 73.97% of the companies in the same industry are doing better.
  • CVSA does not score too well on the current and quick ratio evaluation. However, as it has excellent solvency and profitability, these ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
Industry RankSector Rank
Current Ratio 0.68
Quick Ratio 0.68
CVSA Yearly Current Assets VS Current LiabilitesCVSA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. CVSA Growth Analysis

3.1 Past

  • CVSA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 29.98%, which is quite impressive.
  • The Earnings Per Share has been growing by 23.77% on average over the past years. This is a very strong growth
  • The Revenue has grown by 11.92% in the past year. This is quite good.
  • CVSA shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 11.19% yearly.
EPS 1Y (TTM)29.98%
EPS 3Y23.46%
EPS 5Y23.77%
EPS Q2Q%34.25%
Revenue 1Y (TTM)11.92%
Revenue growth 3Y8.97%
Revenue growth 5Y11.19%
Sales Q2Q%12.43%

3.2 Future

  • CVSA is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 17.34% yearly.
  • CVSA is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.33% yearly.
EPS Next Y20.63%
EPS Next 2Y17.2%
EPS Next 3Y17.34%
EPS Next 5YN/A
Revenue Next Year8.63%
Revenue Next 2Y7.62%
Revenue Next 3Y7.99%
Revenue Next 5Y8.33%

3.3 Evolution

  • Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CVSA Yearly Revenue VS EstimatesCVSA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 500M 1B 1.5B 2B
CVSA Yearly EPS VS EstimatesCVSA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2 4 6 8 10

More info and screens

Find the best growth stocksShow best growing peers

8

4. CVSA Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 13.72, the valuation of CVSA can be described as correct.
  • CVSA's Price/Earnings ratio is a bit cheaper when compared to the industry. CVSA is cheaper than 72.60% of the companies in the same industry.
  • CVSA is valuated rather cheaply when we compare the Price/Earnings ratio to 25.23, which is the current average of the S&P500 Index.
  • CVSA is valuated reasonably with a Price/Forward Earnings ratio of 11.61.
  • Based on the Price/Forward Earnings ratio, CVSA is valued cheaper than 84.93% of the companies in the same industry.
  • CVSA is valuated cheaply when we compare the Price/Forward Earnings ratio to 23.28, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 13.72
Fwd PE 11.61
CVSA Price Earnings VS Forward Price EarningsCVSA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • CVSA's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. CVSA is cheaper than 67.12% of the companies in the same industry.
  • CVSA's Price/Free Cash Flow ratio is rather cheap when compared to the industry. CVSA is cheaper than 84.93% of the companies in the same industry.
Industry RankSector Rank
P/FCF 9.99
EV/EBITDA 9.76
CVSA Per share dataCVSA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • CVSA has an outstanding profitability rating, which may justify a higher PE ratio.
  • CVSA's earnings are expected to grow with 17.34% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.67
PEG (5Y)0.58
EPS Next 2Y17.2%
EPS Next 3Y17.34%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. CVSA Dividend Analysis

5.1 Amount

  • No dividends for CVSA!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

CVSA Fundamentals: All Metrics, Ratios and Statistics

COVISTA INC

NYSE:CVSA (3/20/2026, 8:04:00 PM)

After market: 106.49 0 (0%)

106.49

-0.49 (-0.46%)

Chartmill FA Rating
GICS IndustryGroupConsumer Services
GICS IndustryDiversified Consumer Services
Earnings (Last)01-28
Earnings (Next)05-06
Inst Owners102.79%
Inst Owner ChangeN/A
Ins Owners1.45%
Ins Owner Change10.46%
Market Cap3.67B
Revenue(TTM)1.89B
Net Income(TTM)253.25M
Analysts88
Price TargetN/A
Short Float %5.45%
Short Ratio4.04
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)8.83%
Min EPS beat(2)8.76%
Max EPS beat(2)8.91%
EPS beat(4)4
Avg EPS beat(4)9.44%
Min EPS beat(4)6.2%
Max EPS beat(4)13.91%
EPS beat(8)8
Avg EPS beat(8)13.85%
EPS beat(12)12
Avg EPS beat(12)14.37%
EPS beat(16)16
Avg EPS beat(16)13.93%
Revenue beat(2)2
Avg Revenue beat(2)0.59%
Min Revenue beat(2)0.2%
Max Revenue beat(2)0.98%
Revenue beat(4)4
Avg Revenue beat(4)1.27%
Min Revenue beat(4)0.2%
Max Revenue beat(4)2.26%
Revenue beat(8)8
Avg Revenue beat(8)1.79%
Revenue beat(12)12
Avg Revenue beat(12)1.77%
Revenue beat(16)14
Avg Revenue beat(16)7.41%
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 13.72
Fwd PE 11.61
P/S 1.95
P/FCF 9.99
P/OCF 8.59
P/B 2.67
P/tB N/A
EV/EBITDA 9.76
EPS(TTM)7.76
EY7.29%
EPS(NY)9.17
Fwd EY8.62%
FCF(TTM)10.66
FCFY10.01%
OCF(TTM)12.4
OCFY11.64%
SpS54.73
BVpS39.95
TBVpS-9.92
PEG (NY)0.67
PEG (5Y)0.58
Graham Number83.52
Profitability
Industry RankSector Rank
ROA 9.69%
ROE 18.37%
ROCE 17%
ROIC 13.77%
ROICexc 14.13%
ROICexgc 75.81%
OM 19.55%
PM (TTM) 13.41%
GM 57.38%
FCFM 19.48%
ROA(3y)5.64%
ROA(5y)5.9%
ROE(3y)10.98%
ROE(5y)11.83%
ROIC(3y)9.63%
ROIC(5y)7.66%
ROICexc(3y)10.68%
ROICexc(5y)8.65%
ROICexgc(3y)69.89%
ROICexgc(5y)49.9%
ROCE(3y)11.9%
ROCE(5y)9.46%
ROICexgc growth 3Y43.58%
ROICexgc growth 5Y21.13%
ROICexc growth 3Y34.8%
ROICexc growth 5Y6.87%
OM growth 3Y19.65%
OM growth 5Y4.08%
PM growth 3Y-16.17%
PM growth 5YN/A
GM growth 3Y2.86%
GM growth 5Y1.26%
F-Score8
Asset Turnover0.72
Health
Industry RankSector Rank
Debt/Equity 0.37
Debt/FCF 1.37
Debt/EBITDA 1.19
Cap/Depr 112.6%
Cap/Sales 3.17%
Interest Coverage 250
Cash Conversion 101.29%
Profit Quality 145.32%
Current Ratio 0.68
Quick Ratio 0.68
Altman-Z 4.47
F-Score8
WACC8.73%
ROIC/WACC1.58
Cap/Depr(3y)65.95%
Cap/Depr(5y)64.36%
Cap/Sales(3y)2.82%
Cap/Sales(5y)3.22%
Profit Quality(3y)159.84%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)29.98%
EPS 3Y23.46%
EPS 5Y23.77%
EPS Q2Q%34.25%
EPS Next Y20.63%
EPS Next 2Y17.2%
EPS Next 3Y17.34%
EPS Next 5YN/A
Revenue 1Y (TTM)11.92%
Revenue growth 3Y8.97%
Revenue growth 5Y11.19%
Sales Q2Q%12.43%
Revenue Next Year8.63%
Revenue Next 2Y7.62%
Revenue Next 3Y7.99%
Revenue Next 5Y8.33%
EBIT growth 1Y11.93%
EBIT growth 3Y30.39%
EBIT growth 5Y15.73%
EBIT Next Year38.69%
EBIT Next 3Y18.01%
EBIT Next 5YN/A
FCF growth 1Y87.3%
FCF growth 3YN/A
FCF growth 5Y35.23%
OCF growth 1Y68.41%
OCF growth 3Y217.06%
OCF growth 5Y25.69%

COVISTA INC / CVSA Fundamental Analysis FAQ

What is the ChartMill fundamental rating of COVISTA INC (CVSA) stock?

ChartMill assigns a fundamental rating of 7 / 10 to CVSA.


Can you provide the valuation status for COVISTA INC?

ChartMill assigns a valuation rating of 8 / 10 to COVISTA INC (CVSA). This can be considered as Undervalued.


What is the profitability of CVSA stock?

COVISTA INC (CVSA) has a profitability rating of 8 / 10.


Can you provide the PE and PB ratios for CVSA stock?

The Price/Earnings (PE) ratio for COVISTA INC (CVSA) is 13.72 and the Price/Book (PB) ratio is 2.67.


What is the financial health of COVISTA INC (CVSA) stock?

The financial health rating of COVISTA INC (CVSA) is 7 / 10.